XML 143 R3.htm IDEA: XBRL DOCUMENT

Award Timing Disclosure

12 Months Ended

Dec. 31, 2024

Feb. 21, 2024

USD ($)

$ / shares

Award Timing Disclosures [Line Items]

Award Timing MNPI Disclosure

Timing of Equity Awards and Grant Practices

•The Committee’s long-standing practice is to approve and grant annual LTI awards, including stock options, on a pre-determined schedule in the first quarter of each year in accordance with the company’s annual compensation cycle. Not only does this timing allow the Committee to align equity awards with our annual performance and business goals but it also prevents intentionally timing such grants in anticipation of the release of material nonpublic information (MNPI). Our disclosure of MNPI is also not timed on the basis of equity award grant dates.

•In addition, the Committee may at times grant equity incentive awards, including stock options, to newly hired or promoted employees or to recognize executives outside of the annual grant cycle. In such cases, the effective date of the grant, or the grant date, will be the third day of the month following such hire or promotion, or if such date is not a trading day, the next trading day, as approved by the Committee. All equity awards granted through this process are conditioned on the employee being an active employee on the grant date. The exercise price of any stock option to purchase our common stock will be the closing market price of our common stock on the grant date on the principal national securities exchange on which our common stock is listed or admitted to trade. For additional information on the Committee’s practices, see page 37.

As required by Item 402(x) of Regulation S-K under the Exchange Act, we are providing the following information about the stock options granted to our NEOs on February 21, 2024, the same business day on which we filed our Form 10-K for the fiscal year ended December 31, 2023.


Name (a)	Grant date (b)	Number of securities underlying the award (c)	Exercise price of the award ($/Sh) (d)			Grant date fair value of the award (e)			Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information (f)
Mr. Wilson	2/21/2024	119,784		$	159.17		$	4,736,259	0.29	%
Mr. Merten	2/21/2024	18,209		$	159.17		$	719,984	0.29	%
Mr. Rizzo	2/21/2024	22,129		$	159.17		$	874,981	0.29	%
Mr. Dugenske	2/21/2024	18,810		$	159.17		$	743,747	0.29	%
Ms. DeBiase	2/21/2024	10,926		$	159.17		$	432,014	0.29	%

Award Timing Method

The Committee’s long-standing practice is to approve and grant annual LTI awards, including stock options, on a pre-determined schedule in the first quarter of each year in accordance with the company’s annual compensation cycle. Not only does this timing allow the Committee to align equity awards with our annual performance and business goals but it also prevents intentionally timing such grants in anticipation of the release of material nonpublic information (MNPI). Our disclosure of MNPI is also not timed on the basis of equity award grant dates. •In addition, the Committee may at times grant equity incentive awards, including stock options, to newly hired or promoted employees or to recognize executives outside of the annual grant cycle. In such cases, the effective date of the grant, or the grant date, will be the third day of the month following such hire or promotion, or if such date is not a trading day, the next trading day, as approved by the Committee. All equity awards granted through this process are conditioned on the employee being an active employee on the grant date. The exercise price of any stock option to purchase our common stock will be the closing market price of our common stock on the grant date on the principal national securities exchange on which our common stock is listed or admitted to trade.

Award Timing Predetermined

true

Awards Close in Time to MNPI Disclosures, Table


Name (a)	Grant date (b)	Number of securities underlying the award (c)	Exercise price of the award ($/Sh) (d)			Grant date fair value of the award (e)			Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information (f)
Mr. Wilson	2/21/2024	119,784		$	159.17		$	4,736,259	0.29	%
Mr. Merten	2/21/2024	18,209		$	159.17		$	719,984	0.29	%
Mr. Rizzo	2/21/2024	22,129		$	159.17		$	874,981	0.29	%
Mr. Dugenske	2/21/2024	18,810		$	159.17		$	743,747	0.29	%
Ms. DeBiase	2/21/2024	10,926		$	159.17		$	432,014	0.29	%